Rapid Response
Echinacea Use and the Need for More Studies
Abstract
The use of echinacea in the general population is common despite the continued debate on its efficacy in the scientific community. A previously published meta-analysis by Melchart et al1 and a new analysis by Shah et al2 seek to clarify the controversy on the benefits of echinacea in treating and preventing the common cold. Both analyses focus on randomized placebo-controlled trials; however, Shah et al2 includes an analysis on the prevention as well as duration of colds. In Shah et al,2 14 studies were selected out of 738 studies that were reviewed. Nine of the 14 studies contained information on the incidence of colds. Aggregate results from these nine studies showed a reduced incidence of colds in the echinacea-treated group (OR = 0.42, 95%, CI = 0.25–0.71). However, the effect size (odds ratio) was not consistent across the studies (heterogeneity test, Q statistic P < 0.001).This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.